114 related articles for article (PubMed ID: 38488127)
21. Overexpression of LncRNA AC067945.2 Down-Regulates Collagen Expression in Skin Fibroblasts and Possibly Correlates with the VEGF and Wnt Signalling Pathways.
Chen L; Li J; Li Q; Li X; Gao Y; Hua X; Zhou B; Li J
Cell Physiol Biochem; 2018; 45(2):761-771. PubMed ID: 29414824
[TBL] [Abstract][Full Text] [Related]
22. Centella triterpenes cream as a potential drug for the treatment of hypertrophic scar through inhibiting the phosphorylation of STAT3: A network pharmacology analysis and in vitro experiments.
Tan M; Wu D; Zhou Y; Duan B
J Cosmet Dermatol; 2023 Dec; 22(12):3511-3519. PubMed ID: 37563868
[TBL] [Abstract][Full Text] [Related]
23. miR-145 Contributes to Hypertrophic Scarring of the Skin by Inducing Myofibroblast Activity.
Gras C; Ratuszny D; Hadamitzky C; Zhang H; Blasczyk R; Figueiredo C
Mol Med; 2015 Apr; 21(1):296-304. PubMed ID: 25876136
[TBL] [Abstract][Full Text] [Related]
24. Fibroproliferative effect of microRNA-21 in hypertrophic scar derived fibroblasts.
Li G; Zhou R; Zhang Q; Jiang B; Wu Q; Wang C
Exp Cell Res; 2016 Jul; 345(1):93-9. PubMed ID: 27207585
[TBL] [Abstract][Full Text] [Related]
25. The anti-scar effects of basic fibroblast growth factor on the wound repair in vitro and in vivo.
Shi HX; Lin C; Lin BB; Wang ZG; Zhang HY; Wu FZ; Cheng Y; Xiang LJ; Guo DJ; Luo X; Zhang GY; Fu XB; Bellusci S; Li XK; Xiao J
PLoS One; 2013; 8(4):e59966. PubMed ID: 23565178
[TBL] [Abstract][Full Text] [Related]
26. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts.
Zhang Z; Li XJ; Liu Y; Zhang X; Li YY; Xu WS
Burns; 2007 Aug; 33(5):634-41. PubMed ID: 17374457
[TBL] [Abstract][Full Text] [Related]
27. Dynamic biological changes in fibroblasts during hypertrophic scar formation and regression.
Chun Q; ZhiYong W; Fei S; XiQiao W
Int Wound J; 2016 Apr; 13(2):257-62. PubMed ID: 24802644
[TBL] [Abstract][Full Text] [Related]
28. Regulatory mechanism of miR-29 over TGF-β1 and COL1 in scar cells.
Bi S; Cao C; Chai LL; Li SR; Yang DY
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2512-2517. PubMed ID: 28617563
[TBL] [Abstract][Full Text] [Related]
29. Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin.
Fumagalli M; Musso T; Vermi W; Scutera S; Daniele R; Alotto D; Cambieri I; Ostorero A; Gentili F; Caposio P; Zucca M; Sozzani S; Stella M; Castagnoli C
Exp Dermatol; 2007 Jul; 16(7):600-10. PubMed ID: 17576240
[TBL] [Abstract][Full Text] [Related]
30. Effect of THBS1 on the Biological Function of Hypertrophic Scar Fibroblasts.
Jiang D; Guo B; Lin F; Hui Q; Tao K
Biomed Res Int; 2020; 2020():8605407. PubMed ID: 33376743
[TBL] [Abstract][Full Text] [Related]
31. [Signal roles of protein tyrosine kinase in transforming growth factor-beta1, or interferon-gamma regulated proliferation and collagen synthesis by fibroblasts from hypertrophic scar and normal dermis].
Zhang XF; Li HY; Lu KH; Guo SZ; Zhang LX
Zhonghua Zheng Xing Wai Ke Za Zhi; 2005 Jan; 21(1):36-9. PubMed ID: 15844596
[TBL] [Abstract][Full Text] [Related]
32. Thrombospondin-4 critically controls transforming growth factor β1 induced hypertrophic scar formation.
Qian W; Li N; Cao Q; Fan J
J Cell Physiol; 2018 Jan; 234(1):731-739. PubMed ID: 30132849
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-519d inhibits proliferation and induces apoptosis of human hypertrophic scar fibroblasts through targeting Sirtuin 7.
Zhou X; Xie Y; Xiao H; Deng X; Wang Y; Jiang L; Liu C; Zhou R
Biomed Pharmacother; 2018 Apr; 100():184-190. PubMed ID: 29428666
[TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin type A attenuates hypertrophic scar formation via the inhibition of TGF-β1/Smad and ERK pathways.
Li YH; Yang J; Zheng Z; Hu DH; Wang ZD
J Cosmet Dermatol; 2021 May; 20(5):1374-1380. PubMed ID: 33185943
[TBL] [Abstract][Full Text] [Related]
35. Strategy for hypertrophic scar therapy: Improved delivery of triamcinolone acetonide using mechanically robust tip-concentrated dissolving microneedle array.
Lin S; Quan G; Hou A; Yang P; Peng T; Gu Y; Qin W; Liu R; Ma X; Pan X; Liu H; Wang L; Wu C
J Control Release; 2019 Jul; 306():69-82. PubMed ID: 31145948
[TBL] [Abstract][Full Text] [Related]
36. Hypertrophic scar regression is linked to the occurrence of endothelial dysfunction.
Wang XQ; Song F; Liu YK
PLoS One; 2017; 12(5):e0176681. PubMed ID: 28472181
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of TGF-β peptide antagonist on the fibrotic phenotype of human hypertrophic scar fibroblasts.
Wang X; Gao Z; Wu X; Zhang W; Zhou G; Liu W
Pharm Biol; 2016 Jul; 54(7):1189-97. PubMed ID: 26135051
[TBL] [Abstract][Full Text] [Related]
38. Zeolitic imidazole framework-8 loaded gelatin methacryloyl microneedles: A transdural and controlled-release drug delivery system attenuates neuroinflammation after spinal cord injury.
Chen K; Li B; Xu H; Wu J; Li J; Sun W; Fang M; Wang W; Wang S; Zhai X
Int J Biol Macromol; 2024 Jan; 256(Pt 1):128388. PubMed ID: 38016601
[TBL] [Abstract][Full Text] [Related]
39. MiR-141-3p-Functionalized Exosomes Loaded in Dissolvable Microneedle Arrays for Hypertrophic Scar Treatment.
Meng S; Wei Q; Chen S; Liu X; Cui S; Huang Q; Chu Z; Ma K; Zhang W; Hu W; Li S; Wang Z; Tian L; Zhao Z; Li H; Fu X; Zhang C
Small; 2024 Feb; 20(8):e2305374. PubMed ID: 37724002
[TBL] [Abstract][Full Text] [Related]
40. [Effects of sodium tanshinone II A sulfonate on proliferation of fibroblasts in scar and the mRNA and protein expressions of transforming growth factor beta 1 and alpha smooth muscle actin].
Liu H; Yang HL; Zhou SF; Meng CY
Zhonghua Shao Shang Za Zhi; 2013 Jun; 29(3):294-9. PubMed ID: 24059958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
